跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
P-101
首页
药物
P-101
P-101
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Thickners
US 2010063166 A1
申请人: COGNIS IP MAN GMBH
优先权: 2006
EP
US
WO
3 件公开
Machine and method for filling capsules
US 11951076 B2
申请人: IMA SPA
优先权: 2019
CN
US
2 件公开
Subunit vaccine of Pasteurella multocida in veterinary uses
US 8084043 B2
申请人: CHANG POA-CHUN
优先权: 2007
US
2 件公开
Group I mite polypeptide variants
US 2005142641 A1
申请人: NOVOZYMES AS
优先权: 2004
US
Optimized expression of HPV31 L1 in yeast
US 7276243 B2
申请人: MERCK & CO INC
优先权: 2005
US
TARGETING LIPIDS
EP 4074344 A1
申请人: ARBUTUS BIOPHARMA CORP
优先权: 2007
EP
Preparation method for anthelmintic benzimidazole fenbendazole
CN 102241635 A
申请人: JIANGSU BAOZONG BAODA PHARMACEUTICAL CO LTD
优先权: 2011
CN
Preparation method of fenbendazole which is benzimidazole anti-helminthic drug
CN 106397334 A
申请人: JIANGSU BAOZONG & BAODA PHARMACHEM CO LTD
优先权: 2016
CN
METHOD FOR DECOMPOSING COMPOUND, AND COMPOUND
EP 4279494 A1
申请人: UNIV HOKKAIDO NAT UNIV CORP
优先权: 2020
EP
Preparation method and application of ionic liquid containing flame-retardant elements P and N
CN 117534619 A
申请人: TONGLIAO POWER SUPPLY COMPANY OF STATE GRID EAST INNER MONGOLIA ELECTRIC POWER COMPANY
优先权: 2023
CN
第 1 / 2 页
上一页
下一页
药物
反馈